EXIDINE Drug Patent Profile
✉ Email this page to a colleague
When do Exidine patents expire, and what generic alternatives are available?
Exidine is a drug marketed by Xttrium and is included in four NDAs.
The generic ingredient in EXIDINE is chlorhexidine gluconate. There are fifty-eight drug master file entries for this compound. Fifty-three suppliers are listed for this compound. Additional details are available on the chlorhexidine gluconate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Exidine
A generic version of EXIDINE was approved as chlorhexidine gluconate by BECTON DICKINSON on October 24th, 1989.
Summary for EXIDINE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 4 |
Finished Product Suppliers / Packagers: | 25 |
Raw Ingredient (Bulk) Api Vendors: | 42 |
Patent Applications: | 6,899 |
Formulation / Manufacturing: | see details |
DailyMed Link: | EXIDINE at DailyMed |
Pharmacology for EXIDINE
Physiological Effect | Decreased Cell Wall Integrity |
Anatomical Therapeutic Chemical (ATC) Classes for EXIDINE
US Patents and Regulatory Information for EXIDINE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Xttrium | EXIDINE | chlorhexidine gluconate | AEROSOL, METERED;TOPICAL | 019127-001 | Dec 24, 1984 | OTC | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Xttrium | EXIDINE | chlorhexidine gluconate | SOLUTION;TOPICAL | 019125-001 | Dec 24, 1984 | OTC | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Xttrium | EXIDINE | chlorhexidine gluconate | SOLUTION;TOPICAL | 019422-001 | Dec 17, 1985 | OTC | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |